LURASIDONE HYDROCHLORIDE

LURASIDONE HYDROCHLORIDE was reported 20965 times

LURASIDONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANOSOGNOSIA 433 0.5638
1 BLOOD PROLACTIN ABNORMAL 431 0.4994
2 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 25 0.2000
3 DISTURBANCE IN SOCIAL BEHAVIOUR 418 0.1773
4 ACTIVATION SYNDROME 34 0.0983
5 METABOLIC DISORDER 449 0.0772
6 MANIC SYMPTOM 10 0.0595
7 TONGUE MOVEMENT DISTURBANCE 49 0.0572
8 METAMYELOCYTE COUNT INCREASED 8 0.0537
9 PERSONALITY CHANGE 419 0.0451
10 MYELOCYTE COUNT INCREASED 8 0.0426
11 AKATHISIA 580 0.0425
12 SEXUAL DYSFUNCTION 488 0.0416
13 TIME PERCEPTION ALTERED 15 0.0413
14 SCHIZOPHRENIA 476 0.0391
15 BIPOLAR II DISORDER 14 0.0389
16 AVERSION 11 0.0382
17 MECONIUM ASPIRATION SYNDROME 8 0.0379
18 MANIA 574 0.0349
19 EMOTIONAL POVERTY 59 0.0336
20 BIPOLAR DISORDER 339 0.0312
21 DYSTONIA 573 0.0295
22 OROMANDIBULAR DYSTONIA 21 0.0288
23 BIPOLAR I DISORDER 63 0.0287
24 ASOCIAL BEHAVIOUR 9 0.0279
25 BLOOD PROLACTIN INCREASED 131 0.0278
26 AUTOPHOBIA 7 0.0276
27 THERAPEUTIC PRODUCT EFFECT INCREASED 32 0.0275
28 GRANDIOSITY 10 0.0273
29 SOLILOQUY 23 0.0266
30 TACHYPHRENIA 92 0.0265
31 HYPOMETABOLISM 10 0.0262
32 OCULOGYRIC CRISIS 55 0.0256
33 PSYCHOTIC SYMPTOM 50 0.0242
34 HYPOMANIA 88 0.0239
35 SEDATION 626 0.0239
36 SCHIZOAFFECTIVE DISORDER 42 0.0235
37 BELLIGERENCE 10 0.0233
38 SUICIDE THREAT 9 0.0230
39 NAIL BED BLEEDING 13 0.0228
40 BORDERLINE PERSONALITY DISORDER 15 0.0211
41 FLAT AFFECT 48 0.0207
42 BOREDOM 7 0.0206
43 PROTRUSION TONGUE 12 0.0206
44 DYSKINESIA 832 0.0205
45 BRUXISM 108 0.0200
46 TARDIVE DYSKINESIA 564 0.0200
47 COGWHEEL RIGIDITY 20 0.0190
48 HALLUCINATION, AUDITORY 296 0.0186
49 METABOLIC SURGERY 21 0.0185
50 WATER INTOXICATION 9 0.0178
51 NEGATIVE THOUGHTS 51 0.0174
52 INTRUSIVE THOUGHTS 20 0.0170
53 AUTOSCOPY 9 0.0167
54 TRISMUS 86 0.0166
55 RESTLESSNESS 603 0.0165
56 GAMBLING DISORDER 44 0.0163
57 BLUNTED AFFECT 12 0.0163
58 VIOLENCE-RELATED SYMPTOM 25 0.0161
59 SELF-DESTRUCTIVE BEHAVIOUR 14 0.0161
60 SEDATION COMPLICATION 41 0.0161
61 COMPULSIVE SEXUAL BEHAVIOUR 13 0.0160
62 REDUCED FACIAL EXPRESSION 16 0.0158
63 PERINATAL DEPRESSION 7 0.0155
64 ORTHOSTATIC HYPERTENSION 9 0.0154
65 HYPERMETABOLISM 8 0.0151
66 GALACTORRHOEA 97 0.0151
67 SEXUALLY INAPPROPRIATE BEHAVIOUR 7 0.0150
68 COMPULSIONS 10 0.0150
69 BINGE EATING 16 0.0148
70 COMPULSIVE SHOPPING 30 0.0146
71 SELF-INJURIOUS IDEATION 61 0.0145
72 OBSESSIVE THOUGHTS 26 0.0144
73 FLASHBACK 8 0.0139
74 TIC 75 0.0137
75 SOCIAL ANXIETY DISORDER 9 0.0137
76 DERMATILLOMANIA 8 0.0134
77 FACIAL SPASM 15 0.0134
78 ENERGY INCREASED 79 0.0134
79 LOGORRHOEA 47 0.0133
80 SUICIDE ATTEMPT 800 0.0132
81 HYPERSEXUALITY 24 0.0131
82 FEELING OF DESPAIR 61 0.0131
83 PARKINSONIAN GAIT 8 0.0128
84 MORNING SICKNESS 7 0.0128
85 GRIMACING 10 0.0128
86 REPETITIVE SPEECH 7 0.0124
87 OCCIPITAL NEURALGIA 7 0.0124
88 CONVERSION DISORDER 24 0.0124
89 PSYCHIATRIC DECOMPENSATION 24 0.0123
90 EXCESSIVE EYE BLINKING 18 0.0122
91 HOMICIDAL IDEATION 48 0.0118
92 FEELINGS OF WORTHLESSNESS 15 0.0115
93 BREAST DISCHARGE 20 0.0114
94 PSYCHOTIC DISORDER 337 0.0114
95 DEPRESSIVE SYMPTOM 40 0.0113
96 IMPULSIVE BEHAVIOUR 42 0.0112
97 SOMATIC SYMPTOM DISORDER 12 0.0111
98 PERSONALITY DISORDER 29 0.0111
99 SUICIDAL IDEATION 1011 0.0110
100 PARANOIA 189 0.0110
101 DISTURBANCE IN SEXUAL AROUSAL 10 0.0109
102 CIRCADIAN RHYTHM SLEEP DISORDER 9 0.0109
103 CHANGE IN SEIZURE PRESENTATION 7 0.0108
104 ABULIA 10 0.0108
105 INDIFFERENCE 8 0.0107
106 GASTRIC BYPASS 23 0.0106
107 HALLUCINATION, TACTILE 7 0.0105
108 DROOLING 70 0.0101
109 PARKINSONISM 97 0.0099
110 PSYCHOTIC BEHAVIOUR 10 0.0098
111 RESTLESS LEGS SYNDROME 177 0.0097
112 TERMINAL INSOMNIA 17 0.0096
113 DELUSIONAL DISORDER, UNSPECIFIED TYPE 7 0.0094
114 POST-TRAUMATIC STRESS DISORDER 62 0.0092
115 DYSPHEMIA 40 0.0091
116 FEELING GUILTY 12 0.0091
117 ANGER 304 0.0090
118 OBSESSIVE-COMPULSIVE DISORDER 72 0.0090
119 DELUSION 138 0.0089
120 DECREASED ACTIVITY 95 0.0088
121 THERAPY CESSATION 451 0.0088
122 HYPERPHAGIA 35 0.0088
123 CATATONIA 46 0.0088
124 AKINESIA 18 0.0087
125 PHYSICAL ASSAULT 18 0.0086
126 POLYDIPSIA 34 0.0086
127 GESTATIONAL HYPERTENSION 11 0.0085
128 DEREALISATION 18 0.0084
129 PRE-EXISTING CONDITION IMPROVED 52 0.0083
130 SCREAMING 51 0.0080
131 LIP DISORDER 15 0.0079
132 METABOLIC SYNDROME 13 0.0079
133 APATHY 115 0.0079
134 CRYING 286 0.0079
135 MAJOR DEPRESSION 57 0.0078
136 HYPERPROLACTINAEMIA 50 0.0077
137 SLEEP PARALYSIS 11 0.0075
138 SUICIDAL BEHAVIOUR 31 0.0074
139 NEUROLEPTIC MALIGNANT SYNDROME 88 0.0074
140 MONOCYTE COUNT DECREASED 9 0.0074
141 PSYCHIATRIC SYMPTOM 53 0.0072
142 HOSTILITY 18 0.0071
143 TORTICOLLIS 15 0.0071
144 EXTRAPYRAMIDAL DISORDER 175 0.0070
145 GLUTEN SENSITIVITY 10 0.0070
146 DISTRACTIBILITY 8 0.0069
147 ENURESIS 28 0.0069
148 PANIC ATTACK 252 0.0069
149 PRODUCT ADMINISTRATION ERROR 138 0.0068
150 BLEPHAROSPASM 42 0.0067
151 TROPONIN I INCREASED 11 0.0066
152 AGORAPHOBIA 9 0.0066
153 SOCIAL AVOIDANT BEHAVIOUR 38 0.0066
154 HEAD TITUBATION 9 0.0065
155 STUPOR 21 0.0065
156 AGGRESSION 325 0.0065
157 INSURANCE ISSUE 99 0.0065
158 SOMNAMBULISM 42 0.0064
159 IMPATIENCE 12 0.0064
160 INTENTIONAL SELF-INJURY 128 0.0063
161 IMPULSE-CONTROL DISORDER 13 0.0063
162 TEMPERATURE REGULATION DISORDER 14 0.0063
163 BODY TEMPERATURE FLUCTUATION 13 0.0062
164 AGITATION 453 0.0062
165 EYE MOVEMENT DISORDER 42 0.0061
166 AFFECTIVE DISORDER 48 0.0061
167 EUPHORIC MOOD 62 0.0060
168 ANTIPSYCHOTIC DRUG LEVEL INCREASED 17 0.0060
169 PERSECUTORY DELUSION 15 0.0060
170 DEPRESSED MOOD 315 0.0060
171 MUSCLE TWITCHING 137 0.0059
172 DECREASED INTEREST 35 0.0059
173 LIBIDO INCREASED 12 0.0059
174 PSYCHOMOTOR HYPERACTIVITY 98 0.0059
175 HYPERSOMNIA 169 0.0059
176 SEIZURE LIKE PHENOMENA 10 0.0059
177 TONGUE BITING 12 0.0058
178 FRUSTRATION TOLERANCE DECREASED 47 0.0058
179 IMPAIRED SELF-CARE 12 0.0058
180 ATTENTION DEFICIT HYPERACTIVITY DISORDER 24 0.0057
181 THINKING ABNORMAL 106 0.0057
182 MENTAL DISORDER 247 0.0057
183 AUTISM SPECTRUM DISORDER 31 0.0056
184 PANIC REACTION 40 0.0055
185 MALLORY-WEISS SYNDROME 7 0.0055
186 MYOCARDITIS 63 0.0055
187 HALLUCINATIONS, MIXED 23 0.0055
188 MEAN CELL HAEMOGLOBIN DECREASED 10 0.0055
189 HUNGER 76 0.0055
190 ILLUSION 9 0.0054
191 MOOD SWINGS 173 0.0054
192 INCREASED APPETITE 103 0.0054
193 IRRITABILITY 324 0.0054
194 ABNORMAL BEHAVIOUR 213 0.0054
195 SOMNOLENCE 1081 0.0054
196 MENTAL FATIGUE 8 0.0053
197 PRESCRIBED UNDERDOSE 106 0.0053
198 FEAR 142 0.0053
199 LAZINESS 9 0.0053
200 DAYDREAMING 8 0.0052
201 PANIC DISORDER 20 0.0052
202 INITIAL INSOMNIA 52 0.0051
203 DEPRESSION 1146 0.0050
204 FORMICATION 35 0.0050
205 MUSCLE RIGIDITY 60 0.0050
206 WITHDRAWAL SYNDROME 209 0.0050
207 COMMUNICATION DISORDER 19 0.0050
208 DISSOCIATION 38 0.0050
209 WEIGHT INCREASED 1104 0.0049
210 FEELING ABNORMAL 1170 0.0049
211 ANORGASMIA 13 0.0048
212 AFFECT LABILITY 46 0.0048
213 NARCOLEPSY 9 0.0048
214 SNORING 18 0.0048
215 FOOD CRAVING 25 0.0047
216 PLEURITIC PAIN 13 0.0047
217 LOSS OF EMPLOYMENT 14 0.0046
218 BRADYKINESIA 27 0.0046
219 PREMATURE SEPARATION OF PLACENTA 7 0.0045
220 MOOD ALTERED 123 0.0045
221 DRUG ADMINISTRATION ERROR 138 0.0045
222 ALCOHOL ABUSE 12 0.0045
223 PRODUCT ADMINISTRATION INTERRUPTED 35 0.0045
224 MIDDLE INSOMNIA 83 0.0044
225 INAPPROPRIATE AFFECT 7 0.0044
226 MUSCLE TIGHTNESS 71 0.0044
227 ANXIETY 1241 0.0044
228 TREMOR 719 0.0043
229 INSULIN RESISTANCE 9 0.0043
230 FEELING DRUNK 32 0.0043
231 INJECTION SITE CELLULITIS 8 0.0043
232 POSTURE ABNORMAL 14 0.0043
233 REBOUND ACID HYPERSECRETION 13 0.0043
234 PITUITARY TUMOUR BENIGN 7 0.0043
235 BREAST ENLARGEMENT 14 0.0043
236 PSYCHOMOTOR RETARDATION 12 0.0043
237 TENSION 26 0.0043
238 MUSCLE CONTRACTIONS INVOLUNTARY 15 0.0043
239 NEAR DEATH EXPERIENCE 14 0.0042
240 AMENORRHOEA 74 0.0042
241 EOSINOPHIL COUNT DECREASED 10 0.0042
242 SALIVARY HYPERSECRETION 42 0.0042
243 WEIGHT ABNORMAL 10 0.0042
244 MENTAL IMPAIRMENT 100 0.0041
245 THERAPY INTERRUPTED 293 0.0041
246 THROMBOCYTOSIS 15 0.0041
247 GESTATIONAL DIABETES 19 0.0040
248 BREAST CYST 7 0.0040
249 DRUG EFFECT LESS THAN EXPECTED 58 0.0039
250 WEIGHT LOSS POOR 20 0.0039
251 PREGNANCY 78 0.0039
252 EMOTIONAL DISORDER 118 0.0038
253 INSOMNIA 1016 0.0038
254 SWOLLEN TONGUE 119 0.0038
255 POOR QUALITY SLEEP 82 0.0038
256 DISORGANISED SPEECH 7 0.0038
257 HYPERVENTILATION 22 0.0038
258 HYPERACUSIS 14 0.0038
259 HYPOPNOEA 13 0.0037
260 APNOEA 29 0.0037
261 BREAST SWELLING 10 0.0037
262 SLOW SPEECH 9 0.0037
263 NIGHTMARE 128 0.0037
264 HANGOVER 13 0.0037
265 SEROTONIN SYNDROME 71 0.0037
266 BRADYPHRENIA 24 0.0037
267 PRODUCT DOSE OMISSION 237 0.0036
268 HALLUCINATION 273 0.0036
269 DRUG SCREEN FALSE POSITIVE 10 0.0036
270 HYPERPARATHYROIDISM SECONDARY 9 0.0036
271 DISTURBANCE IN ATTENTION 192 0.0036
272 EATING DISORDER 75 0.0035
273 READING DISORDER 8 0.0035
274 FOAMING AT MOUTH 7 0.0035
275 YAWNING 9 0.0034
276 PRE-ECLAMPSIA 16 0.0034
277 OVERWEIGHT 18 0.0033
278 LONG QT SYNDROME 8 0.0033
279 TONGUE DISORDER 24 0.0033
280 STARING 8 0.0033
281 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 181 0.0033
282 URINARY RETENTION 110 0.0033
283 HEART RATE ABNORMAL 18 0.0032
284 GLUCOSE TOLERANCE IMPAIRED 19 0.0032
285 FEELING JITTERY 61 0.0032
286 THIRST 57 0.0032
287 GRANULOCYTOPENIA 18 0.0032
288 BLOOD GLUCOSE INCREASED 593 0.0031
289 FEAR OF DEATH 7 0.0031
290 CEREBRAL DISORDER 23 0.0031
291 PHYSICAL DECONDITIONING 8 0.0031
292 TEMPERATURE INTOLERANCE 32 0.0031
293 STRABISMUS 9 0.0031
294 THERAPEUTIC RESPONSE UNEXPECTED 137 0.0031
295 ADVERSE DRUG REACTION 274 0.0030
296 ALCOHOLISM 13 0.0030
297 TEARFULNESS 13 0.0030
298 BRAIN INJURY 30 0.0030
299 BEHAVIOUR DISORDER 16 0.0030
300 ABNORMAL DREAMS 81 0.0029
301 FACIAL PARALYSIS 25 0.0029
302 MOVEMENT DISORDER 94 0.0029
303 COMPLETED SUICIDE 243 0.0029
304 PREMATURE RUPTURE OF MEMBRANES 7 0.0029
305 FEELING OF BODY TEMPERATURE CHANGE 17 0.0029
306 PRIAPISM 10 0.0029
307 SELF ESTEEM DECREASED 7 0.0029
308 MATERNAL DRUGS AFFECTING FOETUS 22 0.0029
309 DRUG EFFECT INCREASED 9 0.0028
310 NERVOUSNESS 148 0.0028
311 ACUTE PSYCHOSIS 7 0.0028
312 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0028
313 TENSION HEADACHE 12 0.0028
314 SINUS TACHYCARDIA 39 0.0027
315 SLUGGISHNESS 28 0.0027
316 COGNITIVE DISORDER 128 0.0027
317 HALLUCINATION, VISUAL 57 0.0027
318 BLOOD TRIGLYCERIDES INCREASED 47 0.0027
319 SPEECH DISORDER 139 0.0027
320 NYSTAGMUS 14 0.0026
321 PRESCRIBED OVERDOSE 51 0.0026
322 ALCOHOL POISONING 7 0.0026
323 SLEEP TERROR 11 0.0026
324 JOINT EFFUSION 18 0.0026
325 ANAL FISSURE 14 0.0026
326 CLONUS 7 0.0026
327 MUSCULOSKELETAL STIFFNESS 224 0.0026
328 RED BLOOD CELL COUNT INCREASED 7 0.0025
329 FACIAL BONES FRACTURE 9 0.0025
330 PHYSICAL DISABILITY 11 0.0025
331 DRUG SCREEN POSITIVE 19 0.0024
332 ANXIETY DISORDER 8 0.0024
333 OFF LABEL USE 2089 0.0024
334 ECONOMIC PROBLEM 36 0.0024
335 DYSARTHRIA 88 0.0023
336 LOSS OF LIBIDO 21 0.0023
337 THROAT TIGHTNESS 63 0.0023
338 ACNE CYSTIC 7 0.0023
339 CRANIOCEREBRAL INJURY 7 0.0023
340 SLEEP DISORDER 162 0.0023
341 WEIGHT FLUCTUATION 24 0.0023
342 IMPAIRED GASTRIC EMPTYING 31 0.0023
343 TREATMENT NONCOMPLIANCE 124 0.0023
344 APPETITE DISORDER 15 0.0023
345 RALES 13 0.0022
346 MEMORY IMPAIRMENT 306 0.0022
347 MATERNAL EXPOSURE DURING BREAST FEEDING 9 0.0022
348 ELECTROENCEPHALOGRAM ABNORMAL 7 0.0022
349 SLEEP APNOEA SYNDROME 42 0.0022
350 EAR DISORDER 10 0.0022
351 DRUG TOLERANCE 11 0.0022
352 DYSPHORIA 11 0.0022
353 BLOOD ALBUMIN DECREASED 17 0.0021
354 DYSGRAPHIA 14 0.0021
355 CONDITION AGGRAVATED 646 0.0021
356 FOETAL DEATH 11 0.0021
357 MOUTH SWELLING 12 0.0021
358 ATELECTASIS 20 0.0021
359 THERAPEUTIC PRODUCT EFFECT VARIABLE 8 0.0021
360 AMNESIA 134 0.0021
361 IMPAIRED DRIVING ABILITY 23 0.0020
362 ANHEDONIA 53 0.0020
363 EXPOSURE VIA BREAST MILK 8 0.0020
364 COORDINATION ABNORMAL 28 0.0020
365 CHOKING SENSATION 11 0.0020
366 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 400 0.0020
367 HYPERHIDROSIS 253 0.0020
368 AMMONIA INCREASED 10 0.0020
369 FRUSTRATION 7 0.0020
370 PREMATURE LABOUR 11 0.0019
371 APPARENT DEATH 7 0.0019
372 NEPHROGENIC ANAEMIA 9 0.0019
373 PERONEAL NERVE PALSY 11 0.0019
374 SOCIAL PROBLEM 8 0.0019
375 MONOCYTE COUNT INCREASED 7 0.0019
376 DYSSTASIA 56 0.0019
377 PARADOXICAL DRUG REACTION 7 0.0019
378 ALCOHOL USE 7 0.0019
379 MATERNAL EXPOSURE DURING PREGNANCY 169 0.0019
380 SEIZURE 218 0.0019
381 ELECTROCARDIOGRAM QT PROLONGED 67 0.0019
382 CONFUSIONAL STATE 300 0.0019
383 INCOHERENT 12 0.0019
384 SUBSTANCE ABUSE 15 0.0018
385 UNDERDOSE 134 0.0018
386 COELIAC DISEASE 18 0.0018
387 CLAVICLE FRACTURE 7 0.0018
388 FEEDING DISORDER 37 0.0018
389 OBESITY 29 0.0018
390 PHARYNGEAL OEDEMA 28 0.0018
391 GRIP STRENGTH DECREASED 16 0.0018
392 LOW DENSITY LIPOPROTEIN INCREASED 14 0.0018
393 FACIAL PAIN 16 0.0018
394 GLYCOSYLATED HAEMOGLOBIN INCREASED 45 0.0018
395 MOTOR DYSFUNCTION 18 0.0018
396 PAIN IN JAW 50 0.0018
397 HYPERCHOLESTEROLAEMIA 17 0.0018
398 HIDRADENITIS 16 0.0018
399 RESPIRATION ABNORMAL 12 0.0017
400 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 51 0.0017
401 PSYCHOLOGICAL TRAUMA 15 0.0017
402 THERAPY CHANGE 17 0.0017
403 FEELING COLD 48 0.0017
404 MALABSORPTION 9 0.0017
405 INTENTIONAL DOSE OMISSION 49 0.0017
406 ERECTILE DYSFUNCTION 44 0.0017
407 SENSORY DISTURBANCE 27 0.0017
408 CONCUSSION 13 0.0017
409 LETHARGY 96 0.0017
410 BRAIN FOG 26 0.0017
411 HYPOKINESIA 24 0.0017
412 MUSCLE FATIGUE 7 0.0017
413 THERAPY NON-RESPONDER 74 0.0016
414 NIGHT SWEATS 53 0.0016
415 HEAD DISCOMFORT 29 0.0016
416 DEAFNESS UNILATERAL 9 0.0016
417 POLLAKIURIA 68 0.0016
418 DRUG INTERACTION 256 0.0016
419 BLOOD CHOLESTEROL INCREASED 75 0.0016
420 BLOOD TESTOSTERONE DECREASED 11 0.0016
421 JOINT DISLOCATION 17 0.0016
422 SPINAL OSTEOARTHRITIS 14 0.0016
423 LIGAMENT RUPTURE 7 0.0016
424 PALPITATIONS 185 0.0016
425 THERAPEUTIC RESPONSE CHANGED 10 0.0016
426 GENERALISED TONIC-CLONIC SEIZURE 26 0.0016
427 MENSTRUAL DISORDER 13 0.0016
428 FEELING HOT 96 0.0016
429 NOCTURIA 19 0.0016
430 MIGRAINE 148 0.0015
431 DRUG USE DISORDER 13 0.0015
432 CAESAREAN SECTION 18 0.0015
433 PARALYSIS 22 0.0015
434 MALAISE 673 0.0015
435 OBSTRUCTIVE AIRWAYS DISORDER 17 0.0015
436 DYSPHAGIA 145 0.0015
437 APHASIA 46 0.0015
438 CORONAVIRUS INFECTION 10 0.0015
439 DIABETES MELLITUS 115 0.0015
440 ACCIDENT 18 0.0015
441 PERFORMANCE STATUS DECREASED 7 0.0015
442 WEIGHT DECREASED 417 0.0015
443 DRY MOUTH 121 0.0015
444 PHOTOPHOBIA 28 0.0015
445 PRODUCT RESIDUE PRESENT 8 0.0015
446 MUSCLE DISORDER 12 0.0015
447 JAW DISORDER 8 0.0015
448 VOMITING 682 0.0014
449 RASH VESICULAR 7 0.0014
450 FOOT DEFORMITY 16 0.0014
451 LIP SWELLING 48 0.0014
452 DRUG INEFFECTIVE 1897 0.0014
453 CHRONIC KIDNEY DISEASE 109 0.0014
454 SOPOR 19 0.0014
455 PHARYNGEAL SWELLING 14 0.0014
456 MYOCLONUS 17 0.0014
457 BODY TEMPERATURE INCREASED 29 0.0014
458 INCONTINENCE 15 0.0014
459 URINARY INCONTINENCE 42 0.0014
460 ARRHYTHMIA 67 0.0014
461 IMPAIRED WORK ABILITY 30 0.0014
462 MUSCLE SPASMS 257 0.0014
463 HYPERTONIA 8 0.0014
464 INTENTIONAL OVERDOSE 89 0.0014
465 ALTERED STATE OF CONSCIOUSNESS 30 0.0014
466 LACERATION 13 0.0014
467 RESPIRATORY RATE INCREASED 12 0.0014
468 POLYURIA 11 0.0013
469 NAUSEA 1061 0.0013
470 ROAD TRAFFIC ACCIDENT 56 0.0013
471 EMOTIONAL DISTRESS 161 0.0013
472 HEAD INJURY 42 0.0013
473 PAROSMIA 10 0.0013
474 BLOOD CREATINE PHOSPHOKINASE INCREASED 38 0.0013
475 HYPERTHERMIA 10 0.0013
476 ILLNESS 134 0.0013
477 SPINAL OPERATION 16 0.0013
478 JOINT STIFFNESS 34 0.0013
479 VISION BLURRED 177 0.0013
480 DISORIENTATION 51 0.0013
481 GAIT INABILITY 43 0.0013
482 HAND FRACTURE 9 0.0013
483 TOOTH FRACTURE 14 0.0013
484 NEUTROPHIL COUNT INCREASED 13 0.0013
485 RED BLOOD CELL SEDIMENTATION RATE INCREASED 14 0.0013
486 JOINT INJURY 27 0.0013
487 UPPER LIMB FRACTURE 25 0.0013
488 IMPAIRED QUALITY OF LIFE 18 0.0013
489 MALNUTRITION 14 0.0013
490 DISCOMFORT 76 0.0012
491 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
492 INTENTIONAL UNDERDOSE 9 0.0012
493 HEART RATE INCREASED 122 0.0012
494 ANKLE FRACTURE 19 0.0012
495 NODULE 16 0.0012
496 FATIGUE 954 0.0012
497 NEUROLOGICAL SYMPTOM 7 0.0012
498 WALKING AID USER 8 0.0012
499 INABILITY TO AFFORD MEDICATION 12 0.0012
500 SUNBURN 9 0.0012
501 LOSS OF CONSCIOUSNESS 154 0.0012
502 BREAST TENDERNESS 9 0.0012
503 COLD SWEAT 21 0.0012
504 TOOTH ABSCESS 12 0.0012
505 DIPLOPIA 30 0.0012
506 HYSTERECTOMY 10 0.0012
507 PRODUCT USE IN UNAPPROVED INDICATION 285 0.0011
508 ABORTION SPONTANEOUS 46 0.0011
509 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
510 BALANCE DISORDER 99 0.0011
511 ABDOMINAL DISCOMFORT 191 0.0011
512 DIZZINESS POSTURAL 11 0.0011
513 LIMB DISCOMFORT 35 0.0011
514 CYST 14 0.0011
515 HYPOAESTHESIA ORAL 17 0.0011
516 RETCHING 24 0.0011
517 BREAST PAIN 12 0.0011
518 DIZZINESS 560 0.0011
519 PNEUMONIA ASPIRATION 28 0.0011
520 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
521 SENSORY LOSS 9 0.0011
522 MYOSITIS 10 0.0011
523 LIGAMENT SPRAIN 11 0.0011
524 GAIT DISTURBANCE 212 0.0011
525 PHOTOPSIA 7 0.0011
526 VISUAL FIELD DEFECT 8 0.0011
527 HEART RATE IRREGULAR 25 0.0011
528 ASPHYXIA 9 0.0011
529 FALL 365 0.0011
530 HYPOPHAGIA 28 0.0011
531 PRODUCT PRESCRIBING ERROR 26 0.0011
532 MYDRIASIS 14 0.0011
533 ORTHOSTATIC HYPOTENSION 19 0.0011
534 HYPERGLYCAEMIA 39 0.0011
535 PRESYNCOPE 26 0.0011
536 DECREASED APPETITE 247 0.0011
537 DISABILITY 21 0.0011
538 SEASONAL ALLERGY 15 0.0011
539 NERVOUS SYSTEM DISORDER 33 0.0011
540 BLOOD PRESSURE ABNORMAL 21 0.0011
541 VITAMIN D DECREASED 9 0.0011
542 GASTROENTERITIS VIRAL 19 0.0011
543 RENAL PAIN 11 0.0010
544 PRODUCT LABEL ISSUE 7 0.0010
545 CHOKING 20 0.0010
546 HEPATIC STEATOSIS 19 0.0010
547 KIDNEY INFECTION 20 0.0010
548 ONYCHOCLASIS 7 0.0010
549 WHITE BLOOD CELL COUNT INCREASED 39 0.0010
550 DELIRIUM 35 0.0010
551 TRANSIENT ISCHAEMIC ATTACK 34 0.0010
552 THERAPEUTIC PRODUCT EFFECT DECREASED 45 0.0010
553 ASPIRATION 11 0.0010
554 DRUG DOSE OMISSION 166 0.0010
555 DEMENTIA 28 0.0010
556 CARPAL TUNNEL SYNDROME 14 0.0010
557 HYPERSENSITIVITY 185 0.0010
558 DENTAL CARIES 11 0.0010
559 EPILEPSY 30 0.0010
560 BRAIN NEOPLASM 9 0.0010
561 TINNITUS 45 0.0010
562 PHOTOSENSITIVITY REACTION 16 0.0010
563 SWELLING FACE 63 0.0010
564 PREMATURE BABY 29 0.0010
565 MICTURITION URGENCY 11 0.0010
566 DRUG ABUSE 80 0.0010
567 FOETAL EXPOSURE DURING PREGNANCY 78 0.0010
568 SINUS DISORDER 19 0.0010
569 BLOOD SODIUM DECREASED 18 0.0010
570 HYPOAESTHESIA 142 0.0009
571 PERIPHERAL COLDNESS 13 0.0009
572 ARTHROPOD BITE 7 0.0009
573 TREATMENT FAILURE 78 0.0009
574 TACHYCARDIA 83 0.0009
575 END STAGE RENAL DISEASE 17 0.0009
576 PRURITUS GENERALISED 20 0.0009
577 BACK INJURY 10 0.0009
578 WRIST FRACTURE 11 0.0009
579 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 44 0.0009
580 BLOOD PRESSURE INCREASED 140 0.0009
581 KNEE OPERATION 9 0.0009
582 URTICARIA 153 0.0009
583 THYROID DISORDER 14 0.0009
584 ANGIOEDEMA 40 0.0009
585 VISUAL IMPAIRMENT 112 0.0009
586 EXPOSURE DURING PREGNANCY 56 0.0009
587 MENTAL STATUS CHANGES 25 0.0009
588 NICOTINE DEPENDENCE 7 0.0009
589 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 64 0.0009
590 FRACTURE 17 0.0009
591 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
592 REBOUND EFFECT 10 0.0009
593 DRUG LEVEL DECREASED 9 0.0009
594 HAIR COLOUR CHANGES 11 0.0009
595 TOOTHACHE 16 0.0009
596 LIP DRY 8 0.0009
597 METRORRHAGIA 15 0.0009
598 EAR DISCOMFORT 9 0.0009
599 RENAL INJURY 26 0.0009
600 BLOOD DISORDER 7 0.0009
601 BACK DISORDER 14 0.0009
602 EYE SWELLING 32 0.0009
603 HEADACHE 539 0.0009
604 LEUKOPENIA 43 0.0009
605 SCRATCH 9 0.0009
606 CHILLS 100 0.0009
607 SURGERY 50 0.0009
608 SUDDEN DEATH 9 0.0008
609 RASH GENERALISED 22 0.0008
610 LEUKAEMIA 8 0.0008
611 CHEST PAIN 157 0.0008
612 FOOT FRACTURE 16 0.0008
613 EOSINOPHIL COUNT INCREASED 7 0.0008
614 IRRITABLE BOWEL SYNDROME 18 0.0008
615 HYPERLIPIDAEMIA 10 0.0008
616 LOWER LIMB FRACTURE 16 0.0008
617 TYPE 2 DIABETES MELLITUS 28 0.0008
618 PHARYNGITIS STREPTOCOCCAL 9 0.0008
619 SKIN LACERATION 9 0.0008
620 SKIN DISCOLOURATION 38 0.0008
621 EAR INFECTION 22 0.0008
622 THERAPEUTIC RESPONSE DECREASED 50 0.0008
623 GASTROOESOPHAGEAL REFLUX DISEASE 66 0.0008
624 DRUG RESISTANCE 21 0.0008
625 DEHYDRATION 109 0.0008
626 ASTHENIA 307 0.0008
627 RESPIRATORY DEPRESSION 10 0.0008
628 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 147 0.0008
629 HYPOTHYROIDISM 26 0.0008
630 BLOOD GLUCOSE ABNORMAL 15 0.0008
631 DRUG WITHDRAWAL SYNDROME 71 0.0008
632 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
633 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
634 ABDOMINAL PAIN UPPER 166 0.0008
635 HYPOGLYCAEMIA 39 0.0008
636 DRUG EFFECT INCOMPLETE 29 0.0008
637 HOT FLUSH 60 0.0008
638 TASTE DISORDER 16 0.0008
639 HYPERTENSION 167 0.0008
640 CYSTITIS 25 0.0008
641 SKIN REACTION 11 0.0008
642 UNEVALUABLE EVENT 59 0.0008
643 ROTATOR CUFF SYNDROME 10 0.0008
644 ANAL INCONTINENCE 7 0.0008
645 INTENTIONAL PRODUCT MISUSE 68 0.0008
646 DEVELOPMENTAL DELAY 7 0.0008
647 PARAESTHESIA 122 0.0008
648 UNRESPONSIVE TO STIMULI 20 0.0008
649 LIMB INJURY 21 0.0008
650 RASH MACULAR 27 0.0008
651 TOOTH LOSS 16 0.0008
652 INJECTION SITE INDURATION 10 0.0008
653 C-REACTIVE PROTEIN INCREASED 28 0.0008
654 THERAPY PARTIAL RESPONDER 12 0.0008
655 ABASIA 19 0.0008
656 MUSCULAR WEAKNESS 87 0.0008
657 PARAESTHESIA ORAL 11 0.0008
658 DYSURIA 28 0.0008
659 RENAL FAILURE 101 0.0008
660 SYNCOPE 76 0.0008
661 MYALGIA 129 0.0008
662 ATAXIA 9 0.0008
663 RHINORRHOEA 49 0.0008
664 SNEEZING 17 0.0008
665 PNEUMOTHORAX 12 0.0008
666 RASH PRURITIC 41 0.0008
667 CHROMATURIA 17 0.0008
668 RENAL DISORDER 35 0.0008
669 FUNGAL INFECTION 25 0.0007
670 RENAL IMPAIRMENT 63 0.0007
671 MENSTRUATION IRREGULAR 20 0.0007
672 HYPONATRAEMIA 42 0.0007
673 QUALITY OF LIFE DECREASED 10 0.0007
674 RHABDOMYOLYSIS 31 0.0007
675 NEURALGIA 18 0.0007
676 PRODUCT TASTE ABNORMAL 10 0.0007
677 TACHYPNOEA 10 0.0007
678 BLOOD CREATININE INCREASED 48 0.0007
679 MULTIPLE FRACTURES 12 0.0007
680 PRODUCT SUBSTITUTION ISSUE 42 0.0007
681 GENERALISED OEDEMA 9 0.0007
682 ERUCTATION 14 0.0007
683 VERTIGO 44 0.0007
684 AUTOIMMUNE DISORDER 7 0.0007
685 NECK PAIN 40 0.0007
686 BLINDNESS 29 0.0007
687 RASH ERYTHEMATOUS 34 0.0007
688 MUSCLE ATROPHY 9 0.0007
689 OVERDOSE 153 0.0007
690 CHEST DISCOMFORT 72 0.0007
691 PERIPHERAL SWELLING 108 0.0007
692 PALLOR 19 0.0007
693 NASAL CONGESTION 41 0.0007
694 MUSCULOSKELETAL DISCOMFORT 12 0.0007
695 CONSTIPATION 152 0.0007
696 CARDIAC DISORDER 65 0.0007
697 PLATELET COUNT INCREASED 9 0.0007
698 LYMPHOCYTE COUNT DECREASED 12 0.0007
699 DYSMENORRHOEA 9 0.0007
700 DRUG ERUPTION 12 0.0007
701 NEPHROLITHIASIS 31 0.0007
702 CONTUSION 65 0.0007
703 DYSPNOEA 382 0.0007
704 STEVENS-JOHNSON SYNDROME 15 0.0007
705 PAIN IN EXTREMITY 198 0.0007
706 INJURY 47 0.0007
707 INFLUENZA LIKE ILLNESS 55 0.0007
708 BLOOD GLUCOSE DECREASED 32 0.0007
709 DIABETIC KETOACIDOSIS 16 0.0007
710 DRUG LEVEL INCREASED 11 0.0007
711 THERAPEUTIC RESPONSE SHORTENED 22 0.0007
712 LEUKOCYTOSIS 12 0.0007
713 SWELLING 62 0.0007
714 DYSGEUSIA 49 0.0007
715 HEART RATE DECREASED 23 0.0007
716 PAIN 402 0.0007
717 INTENTIONAL PRODUCT USE ISSUE 57 0.0007
718 RASH 283 0.0006
719 MUSCULOSKELETAL CHEST PAIN 10 0.0006
720 MENSTRUATION DELAYED 7 0.0006
721 OEDEMA 35 0.0006
722 APHONIA 9 0.0006
723 AGEUSIA 16 0.0006
724 PEMPHIGUS 8 0.0006
725 BACK PAIN 148 0.0006
726 ALANINE AMINOTRANSFERASE INCREASED 39 0.0006
727 RIB FRACTURE 13 0.0006
728 MUSCULOSKELETAL DISORDER 12 0.0006
729 NERVE INJURY 7 0.0006
730 PREMATURE DELIVERY 10 0.0006
731 OROPHARYNGEAL PAIN 58 0.0006
732 BLOOD PRESSURE FLUCTUATION 15 0.0006
733 SKIN INFECTION 7 0.0006
734 BLOOD CALCIUM DECREASED 7 0.0006
735 PRODUCT DOSE OMISSION ISSUE 183 0.0006
736 ANOSMIA 9 0.0006
737 DRUG INTOLERANCE 60 0.0006
738 MITRAL VALVE INCOMPETENCE 7 0.0006
739 EAR PAIN 12 0.0006
740 EXTRA DOSE ADMINISTERED 25 0.0006
741 ACUTE KIDNEY INJURY 94 0.0006
742 SCAB 7 0.0006
743 COMA 29 0.0006
744 ANKYLOSING SPONDYLITIS 8 0.0006
745 LIVER FUNCTION TEST INCREASED 13 0.0006
746 VIRAL INFECTION 20 0.0006
747 LACRIMATION INCREASED 18 0.0006
748 TOXICITY TO VARIOUS AGENTS 100 0.0006
749 ECZEMA 31 0.0006
750 HOSPITALISATION 91 0.0006
751 WHITE BLOOD CELL COUNT DECREASED 64 0.0006
752 DYSPEPSIA 58 0.0006
753 DRUG DISPENSING ERROR 9 0.0006
754 NEUTROPHIL COUNT DECREASED 24 0.0006
755 CHOLECYSTITIS 7 0.0006
756 LIVER DISORDER 26 0.0006
757 BURNING SENSATION 41 0.0006
758 COVID-19 102 0.0006
759 INFLAMMATION 30 0.0006
760 GASTROINTESTINAL DISORDER 52 0.0006
761 HEPATITIS C 7 0.0006
762 RESPIRATORY DISTRESS 16 0.0006
763 CHOLELITHIASIS 19 0.0006
764 ANAPHYLACTIC REACTION 32 0.0006
765 PROCEDURAL PAIN 16 0.0006
766 RESPIRATORY TRACT INFECTION 15 0.0006
767 ORAL DISCOMFORT 8 0.0006
768 ABDOMINAL DISTENSION 60 0.0006
769 MASS 8 0.0006
770 BLOOD PRESSURE DECREASED 38 0.0006
771 EOSINOPHILIA 10 0.0006
772 GASTRITIS 15 0.0006
773 PANCREATITIS 30 0.0006
774 OSTEOARTHRITIS 24 0.0006
775 BLOOD POTASSIUM DECREASED 17 0.0006
776 PRURITUS 215 0.0006
777 BRONCHITIS 41 0.0006
778 DYSPHONIA 32 0.0005
779 FLATULENCE 31 0.0005
780 GENITAL HAEMORRHAGE 7 0.0005
781 SKIN HAEMORRHAGE 8 0.0005
782 SKIN DISORDER 18 0.0005
783 AGRANULOCYTOSIS 10 0.0005
784 CELLULITIS 27 0.0005
785 OSTEOPOROSIS 22 0.0005
786 FIBROMYALGIA 13 0.0005
787 PANCREATITIS ACUTE 12 0.0005
788 FLUID RETENTION 27 0.0005
789 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
790 INFLUENZA 59 0.0005
791 HEPATIC ENZYME INCREASED 36 0.0005
792 URINARY TRACT INFECTION 90 0.0005
793 GASTRIC ULCER 10 0.0005
794 SCAR 9 0.0005
795 ANGINA PECTORIS 15 0.0005
796 POST PROCEDURAL COMPLICATION 10 0.0005
797 ALOPECIA 102 0.0005
798 HERNIA 10 0.0005
799 LOCAL SWELLING 9 0.0005
800 MOBILITY DECREASED 37 0.0005
801 MULTIPLE SCLEROSIS RELAPSE 35 0.0005
802 RESPIRATORY ARREST 14 0.0005
803 PRODUCT DISPENSING ERROR 11 0.0005
804 NASOPHARYNGITIS 93 0.0005
805 ASTHMA 57 0.0005
806 ULCER 8 0.0005
807 CEREBROVASCULAR ACCIDENT 85 0.0005
808 DRY EYE 25 0.0005
809 BLISTER 28 0.0005
810 DEAFNESS 13 0.0005
811 PRODUCT PHYSICAL ISSUE 10 0.0005
812 GASTRIC DISORDER 17 0.0005
813 PULMONARY EMBOLISM 47 0.0005
814 ILL-DEFINED DISORDER 30 0.0005
815 NEUTROPENIA 67 0.0005
816 ENCEPHALOPATHY 12 0.0005
817 CARDIOGENIC SHOCK 7 0.0005
818 HYPOACUSIS 21 0.0005
819 VENTRICULAR TACHYCARDIA 8 0.0005
820 HEPATIC FUNCTION ABNORMAL 18 0.0005
821 NEOPLASM MALIGNANT 32 0.0005
822 HYPOKALAEMIA 22 0.0005
823 PERICARDITIS 8 0.0005
824 ABDOMINAL PAIN 110 0.0005
825 JOINT SWELLING 57 0.0005
826 HAEMATOCHEZIA 26 0.0005
827 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
828 DRUG PRESCRIBING ERROR 9 0.0005
829 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
830 PYREXIA 161 0.0005
831 WOUND 13 0.0005
832 ACCIDENTAL OVERDOSE 17 0.0005
833 DRUG EFFECT DECREASED 25 0.0005
834 ACNE 35 0.0005
835 EYE PAIN 26 0.0005
836 SKIN FISSURES 9 0.0005
837 INJECTION SITE MASS 17 0.0005
838 DIARRHOEA 296 0.0005
839 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
840 EYE DISORDER 15 0.0005
841 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
842 GYNAECOMASTIA 14 0.0005
843 COMPLICATION OF DEVICE INSERTION 9 0.0005
844 EXPIRED PRODUCT ADMINISTERED 15 0.0005
845 OEDEMA PERIPHERAL 55 0.0005
846 LIVER FUNCTION TEST ABNORMAL 13 0.0004
847 NEEDLE ISSUE 13 0.0004
848 DRUG-INDUCED LIVER INJURY 14 0.0004
849 GOUT 8 0.0004
850 THROAT IRRITATION 20 0.0004
851 ADVERSE EVENT 41 0.0004
852 BONE PAIN 26 0.0004
853 DISEASE RECURRENCE 21 0.0004
854 RESPIRATORY TRACT CONGESTION 7 0.0004
855 MUSCULOSKELETAL PAIN 23 0.0004
856 PRODUCT PREPARATION ERROR 9 0.0004
857 HAEMATEMESIS 11 0.0004
858 BRADYCARDIA 23 0.0004
859 ARTHRITIS 34 0.0004
860 HAEMOPTYSIS 12 0.0004
861 SINUSITIS 44 0.0004
862 HEPATIC CIRRHOSIS 8 0.0004
863 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
864 ERYTHEMA 87 0.0004
865 BLOOD URINE PRESENT 8 0.0004
866 PRODUCT USE ISSUE 79 0.0004
867 BLOOD UREA INCREASED 7 0.0004
868 ACUTE RESPIRATORY FAILURE 8 0.0004
869 MEDICATION ERROR 23 0.0004
870 LOCALISED INFECTION 10 0.0004
871 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
872 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
873 THROMBOSIS 33 0.0004
874 ARTHRALGIA 168 0.0004
875 CONVULSION 23 0.0004
876 RASH PAPULAR 9 0.0004
877 OCULAR HYPERAEMIA 19 0.0004
878 HYPOTENSION 80 0.0004
879 MULTIPLE SCLEROSIS 19 0.0004
880 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
881 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
882 CARDIAC ARREST 32 0.0004
883 SKIN ULCER 10 0.0004
884 PLEURAL EFFUSION 23 0.0004
885 METABOLIC ACIDOSIS 12 0.0004
886 FLUSHING 38 0.0004
887 JAUNDICE 10 0.0004
888 FREQUENT BOWEL MOVEMENTS 10 0.0004
889 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
890 FAECES DISCOLOURED 8 0.0004
891 INCORRECT DOSE ADMINISTERED 84 0.0004
892 LYMPHADENOPATHY 13 0.0004
893 DRY SKIN 49 0.0004
894 LIVER INJURY 9 0.0004
895 GLAUCOMA 7 0.0004
896 DERMATITIS ATOPIC 19 0.0004
897 TOOTH DISORDER 8 0.0004
898 ORAL HERPES 7 0.0004
899 GLOSSODYNIA 8 0.0004
900 MYOCARDIAL INFARCTION 62 0.0004
901 RECTAL HAEMORRHAGE 15 0.0003
902 HERPES ZOSTER 20 0.0003
903 INJECTION SITE WARMTH 7 0.0003
904 OXYGEN SATURATION DECREASED 19 0.0003
905 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
906 PNEUMONIA 109 0.0003
907 PRODUCT ADHESION ISSUE 12 0.0003
908 RHEUMATOID ARTHRITIS 38 0.0003
909 INJECTION SITE REACTION 23 0.0003
910 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
911 COUGH 91 0.0003
912 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
913 SKIN EXFOLIATION 27 0.0003
914 GENERAL PHYSICAL HEALTH DETERIORATION 37 0.0003
915 CARDIOVASCULAR DISORDER 8 0.0003
916 RED BLOOD CELL COUNT DECREASED 9 0.0003
917 RASH MACULO-PAPULAR 7 0.0003
918 HEPATITIS 8 0.0003
919 CARDIO-RESPIRATORY ARREST 13 0.0003
920 PRODUCT AVAILABILITY ISSUE 7 0.0003
921 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
922 PERICARDIAL EFFUSION 7 0.0003
923 RESPIRATORY DISORDER 9 0.0003
924 EYE PRURITUS 10 0.0003
925 PAIN OF SKIN 8 0.0003
926 SEPSIS 33 0.0003
927 HAEMOGLOBIN DECREASED 30 0.0003
928 DYSPNOEA EXERTIONAL 11 0.0003
929 SKIN LESION 8 0.0003
930 ARTHROPATHY 16 0.0003
931 CEREBRAL INFARCTION 7 0.0003
932 NEUROPATHY PERIPHERAL 27 0.0003
933 HIP FRACTURE 9 0.0003
934 PRODUCT QUALITY ISSUE 38 0.0003
935 DEVICE DISLOCATION 12 0.0003
936 ANAPHYLACTIC SHOCK 7 0.0003
937 ACUTE MYOCARDIAL INFARCTION 8 0.0003
938 LABORATORY TEST ABNORMAL 8 0.0003
939 EPISTAXIS 20 0.0003
940 INTESTINAL OBSTRUCTION 10 0.0003
941 CORONARY ARTERY DISEASE 8 0.0003
942 STOMATITIS 16 0.0003
943 COLITIS 10 0.0003
944 NO ADVERSE EVENT 47 0.0003
945 ATRIAL FIBRILLATION 25 0.0003
946 INFECTION 37 0.0003
947 INJECTION SITE BRUISING 20 0.0003
948 HAEMORRHAGE 26 0.0002
949 PSORIASIS 32 0.0002
950 PLATELET COUNT DECREASED 26 0.0002
951 DRUG DEPENDENCE 39 0.0002
952 SKIN BURNING SENSATION 17 0.0002
953 WHEEZING 14 0.0002
954 INJECTION SITE SWELLING 18 0.0002
955 DEEP VEIN THROMBOSIS 15 0.0002
956 VAGINAL HAEMORRHAGE 10 0.0002
957 INJECTION SITE ERYTHEMA 28 0.0002
958 CEREBRAL HAEMORRHAGE 8 0.0002
959 BONE DENSITY DECREASED 7 0.0002
960 CATARACT 13 0.0002
961 LACTIC ACIDOSIS 7 0.0002
962 PANCYTOPENIA 12 0.0002
963 THROMBOCYTOPENIA 24 0.0002
964 ANAEMIA 39 0.0002
965 LUNG DISORDER 10 0.0002
966 DEPENDENCE 11 0.0002
967 HYPOXIA 7 0.0002
968 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
969 DEVICE BREAKAGE 8 0.0002
970 INJECTION SITE PRURITUS 13 0.0002
971 CARDIAC FAILURE 15 0.0002
972 DEVICE MALFUNCTION 13 0.0002
973 DEATH 159 0.0002
974 INJECTION SITE PAIN 56 0.0002
975 PULMONARY OEDEMA 8 0.0002
976 INJECTION SITE HAEMORRHAGE 14 0.0002
977 SKIN IRRITATION 8 0.0002
978 CARDIAC FAILURE CONGESTIVE 14 0.0002
979 PRODUCTIVE COUGH 8 0.0002
980 RESPIRATORY FAILURE 12 0.0002
981 BREAST CANCER 15 0.0002
982 EYE IRRITATION 9 0.0002
983 DEVICE EXPULSION 10 0.0002
984 INFUSION RELATED REACTION 9 0.0001
985 DEVICE ISSUE 11 0.0001
986 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
987 PRODUCT STORAGE ERROR 10 0.0001
988 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001